CXCL10 and ovarian cancer: Additionally, the combination increased CXCL10 levels in both cell culture and ascites fluid, promoting immune cell recruitment and correlating with reduced tumor burden in models like ID8-VEGF-Defensin, which mirrors human ovarian cancer dynamics.